Oculis Holding share price logo

Oculis Holding

NASDAQ: OCS

Small Cap

$9.27

-0.14

(-1.49%)

as on

Oculis Holding Stock Performance

as on September 26, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $9.10
    $9.47
    downward going graph

    1.83%

    Downside

    2.16%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $9.10
    $34.48
    downward going graph

    1.83%

    Downside

    271.90%

    Upside

    downward going graph

Oculis Holding share price movements today

Previous Close
$9.41
Open
$9.34
Volume
390.3K
Market Cap
$522.5M
Day's Low - High
$9.10 - $9.47
52 Week Low - High
$9.10 - $34.48

Oculis Holding Historical Returns

1 Month Return
-28.53 %
3 Month Return
-22.75 %
1 Year Return
-47.42 %
3 Year Return
-16.11 %
5 Year Return
0 %

Oculis Holding Stock Fundamentals & Key Indicators

Check Oculis Holding market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$522.5M

EPS (TTM)

-1.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.57

Industry PE ratio

-8.07

PEG Ratio

-0.09766853627739015

EBITDA

-78.5M

Revenue (TTM)

243.0K

Profit Margin

35.21%

Return On Equity TTM

-42.92%

Oculis Holding Stock Valuation

Track how Oculis Holding P/E has moved over time to understand its valuation trends.

Oculis Holding in the last 5 years

  • Overview

  • Trends

Lowest (-15.59x)

December 31, 2021

Today (-8.75x)

December 31, 2025

Industry (-8.07x)

December 31, 2025

Highest (-3.18x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -8.75x

Oculis Holding vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oculis Holding with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$522.5MNA-5.5735.21%0.00%
Neutral$77.8B-53.76%-24.41-12.57%0.00%
StrongBuy$132.4B186.58%30.1686.04%0.00%
Buy$82.8B23.34%19.0184.86%0.46%

Stock Returns calculator for Oculis Holding Stock including INR - Dollar returns

The Oculis Holding stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Oculis Holding investment value today

Current value as on today

₹56,754

Returns

-₹43,246

(-43.25%)

Returns from Oculis Holding Stock

-₹47,419 (-47.42%)

Dollar Impact

₹4,173 (+4.17%)

Analyst Recommendation on Oculis Holding Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Oculis Holding. Average target price of $36.6

Oculis Holding Share Price Target

Get share price movements and forecasts by analysts on Oculis Holding.

What analysts predicted

74.67%UPSIDE

Target Price

$36.6

Current Price

$9.27

Analyzed by

6 Analysts

High

$45

Target

$36.60

Low

$20

Oculis Holding target price $36.6, a slight upside of 74.67% compared to current price of $9.27. According to 6 analysts rating.

Indian Investors' Interest in Oculis Holding Stock

Search interest for Oculis Holding Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:12% versus previous 30 day period

Oculis Holding Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
0
0
-
-
-
Gross Profit
-
-
-
-
-
-14
0
-
0
-
Operating Income
-15
-22
-18
-17
-19
-20
-20
-20
-22
-23
EBITDA
-15
-20
-19
-28
-32
-25
-16
-23
-29
-9
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
-
0
0
Income Before Tax
-16
-20
-20
-28
-33
-25
-16
-23
-29
-9
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-16
-20
-20
-28
-33
-25
-16
-23
-29
-9
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-5612.26%
100.00%
0.00%
0.00%
0.00%

Oculis Holding Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
-
Gross Profit
-
-
-
-
-51
-
Operating Income
-12
-13
-32
-80
-73
-79
EBITDA
-12
-13
-31
-87
-85
-93
Interest Expense
2
5
6
1
0
0
Depreciation
0
0
0
0
0
0
Income Before Tax
-14
-18
-38
-88
-85
-94
Income Tax Expense
0
0
0
0
0
0
Net Income
-14
-18
-38
-88
-85
-94
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-7492.27%
0.00%

Oculis Holding Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
-20
-20
-28
-33
-25
-16
-23
-29
-9
Operating Cash Flow
-13
-13
-10
-10
-18
-17
-13
-16
-15
-20
Investing Cash Flow
-1
-18
4
-1
-51
25
-2
-32
-26
-8
Financing Cash Flow
0
51
0
2
103
0
-1
84
24
25
Change in Cash
-13
19
-8
-7
32
4
-17
34
-17
-2

Oculis Holding Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-14
-18
-38
-88
-85
-94
Operating Cash Flow
-12
-13
-25
-53
-47
-62
Investing Cash Flow
0
0
-3
-54
-17
-59
Financing Cash Flow
4
55
1
129
54
178
Change in Cash
-7
41
-26
18
-10
57

Mutual Funds that own Oculis Holding Stock

Check out the Mutual Funds with significant holdings in Oculis Holding.

Funds
Holdings
Shares Held
MUTUAL FUND SERIES TRUST
0.698187%
430000
HARTFORD MUTUAL FUNDS, INC
0.290751%
179068
VANGUARD WHITEHALL FUNDS
0.171557%
105659
HARTFORD SERIES FUND INC
0.102058%
62856
Fidelity Concord Street Trust
0.058551%
36061

Global Institutional Holdings in Oculis Holding

Funds
Holdings
Joseph Edelman
1.31%
MUTUAL FUND SERIES TRUST
0.7%
Michael Rockefeller
0.33%
HARTFORD MUTUAL FUNDS, INC
0.29%
VANGUARD WHITEHALL FUNDS
0.17%

Insights on Oculis Holding

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -29.49M → -9.96M (in $), with an average increase of 195.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 102.7% return, outperforming this stock by 118.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 759.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, OCS stock has moved down by -28.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 261.0K → 243.0K (in $), with an average decrease of 6.9% per quarter

About Oculis Holding

Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medications for various ocular conditions, addressing both the anterior and posterior segments of the eye. A key asset in its therapeutic portfolio is OCS-01, a topical formulation of dexamethasone, currently progressing through Phase 3 clinical trials for the management of diabetic macular edema. Additionally, OCS-02, a topically administered biological candidate, is engaged in Phase 2b clinical studies to treat keratoconjunctivitis sicca, commonly known as dry eye disease. The company is also advancing OCS-05, an innovative neuroprotective agent, which targets acute optic neuritis and an array of other neuro-ophthalmic disorders, including glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. This enterprise maintains its headquarters in Zug, Switzerland.
OrganisationOculis Holding
HeadquartersBahnhofstrasse 7, Zug, ZG, 6300, CH
IndustryBiotechnology
CEORiad Sherif
E-voting on sharesClick here to vote

Key Management of Oculis Holding

Name

Title

Dr. Ramin Tadayoni M.D., Ph.D.

Chief Scientific Officer

Ms. Katie Kazem

Chief Legal Officer

Dr. Riad Sherif M.B.A., M.D.

CEO & Director

Ms. Sylvia Cheung

Chief Financial Officer

Mr. Páll Ragnar Jóhannesson

Chief Business Officer

Ms. Rebecca Weil Ph.D.

Chief Commercial Officer

Dr. Snehal Shah Pharm.D.

President of Research & Development

Dr. Sharon Klier M.D., M.P.H.

Chief Development Officer

Ms. Gudrun Bachmann Ph.D.

Chief Technology Officer

Ms. Virginia R. Dean

Chief Human Resources Officer

FAQs

What is Oculis Holding share price today?

Oculis Holding share price today is $9.27 as on at the close of the market. Oculis Holding share today touched a day high of $9.47 and a low of $9.10.

What is the 52 week high and 52 week low for Oculis Holding share?

Oculis Holding share touched a 52 week high of $34.48 on and a 52 week low of $9.10 on . Oculis Holding stock price today i.e. is closed at $9.27,which is 73.11% down from its 52 week high and 1.87% up from its 52 week low.

What is Oculis Holding's market capitalisation today?

Oculis Holding market capitalisation is $0.00T as on .

How to invest in Oculis Holding Stock (OCS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Oculis Holding on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oculis Holding Shares that will get you 0.1618 shares as per Oculis Holding share price of $9.27 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy Oculis Holding Stock (OCS) from India?

Indian investors can start investing in Oculis Holding (OCS) shares with as little as ₹95.8125 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in Oculis Holding stock (as per the Rupee-Dollar exchange rate as on ). Based on Oculis Holding share’s latest price of $9.27 as on September 26, 2026 at 8:45 am IST, you will get 1.0787 shares of Oculis Holding. Learn more about fractional shares .